header CGT report 540x680@2x

Cell & Gene Therapy:
2023 Market Analysis, CDMO Pricing and Benchmarking

Coming June, 2023
  • 200 pages of Cell & Gene Therapy market analysis
  • 2023 pricing comparison for broad CDMO services
  • Market intelligence for viral vector and plasmid DNA manufacture
  • Over 80 unique Cell & Gene Therapy CDMO profiles
  • Benchmarking of top CDMOs’ proprietary technologies
  • Scientific insights from PhDs, CDMO owners and researchers
header CGT report 540x680@2x

Key market insights for innovators, CDMOs and investors in the Cell & Gene Therapy industry.

01 analytics icon 65x65

Scientific analysis on ATMPs — The New Frontier

Stay up to date with market trends for Cell and Gene Therapies straight from the industry’s KOLs. Our Market Analysis gains insights from CDMO owners, PhDs and researchers across advanced therapeutics. Measure your business against your peers using our robust analysis of AAV, lentiviral and plasmid DNA manufacture.

01 report icon 65x65

Exclusive CDMO pricing data for benchmarking

Our pricing matrix uses data from across the industry so you can make informed decisions for your business. Compare your prices over time against your peers in respect to material costs, infrastructure and development process.

Coming June, 2023

Unequaled price benchmarking and market intelligence for Cell & Gene Therapy manufacturing — all in one report.

The Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking provides

01 bar graph icon 65x65@1x
Current pricing data
for manufacturing across advanced Cell & Gene Therapies
03 pie chart icon 65x65
Over 80 significant CDMO profiles
including capabilities, capacity, proprietary technologies and locations
02 research icon 65x65
Scientific analysis of the manufacturing process
for AAV, lentivirus and plasmid DNA
04 goal icon 65x65
Unique supply chain challenges
and the shift from supply chain to value chain management
05 data analytics icon 65x65
Investment outlook
into new modalities — analyzing economic temperature and regulatory conditions
06 innovation icon 65x65
Innovations and breakthroughs
that are invaluable to the next generation of therapies

Over 1000 hours of data collection and analysis
from interviews, primary research and progressive study

Table of Contents

CGT report form 606x630
Coming June, 2023
Request your copy of the 2023 Cell & Gene Therapy Report

CGT report form 606x630